Apple Watch meets Dexcom G7 — here's how to track your blood glucose levels
And, obviously, any user needs to be wearing the G7 CGM sensor. It's worth noting that the Dexcom G7 monitor, as a Class II ...
MedTech Dive7d
Dexcom’s FDA warning letter reveals unauthorized changes to sensors
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
MedTech Dive8d
Dexcom COO on 15-day glucose sensor, Type 2 coverage
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Medscape9d
Dexcom’s 15-day CGM Adds Wear Time, Accuracy to Current G7
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Zacks Investment Research on MSN6d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval
DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...
Modern Healthcare8d
FDA warns Dexcom over continuous glucose monitor testing
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Yahoo Finance7d
DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor
DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025.